Malignant Infratentorial Neoplasm — Trials

Malignant Infratentorial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

302 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 99
Recruiting: 50
Ph III recruiting: 3
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07694622	Targeting MYC in High-Risk Medulloblastoma(MYCMB)	not yet recruiting	N/A	35	Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER	1	Jul 10, 2026	clinicaltrials
NCT07516353	my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults	not yet recruiting	N/A	143	Dana-Farber Cancer InstituteOTHER	1	Apr 8, 2026